Activity Stream
@moatrx
• 2 weeks ago
Posted a new blog:
US HR-POSITIVE HER2-NEGATIVE BREAST CANCER LAUNCH READINESS
US HR-POSITIVE HER2-NEGATIVE BREAST CANCER LAUNCH READINESS
A 2025 study of 9,146 patients found no survival difference across three first-line CDK4/6 inhibitors, closing that line to new entrants.
A 2025 Flatiron Health...
